A Comparative Study for the Therapeutic Effect and Cognitive Influence of Transcranial Magnetic Stimulation as an Augmentative Treatment Strategy to Treat Patients with Senile Depression

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024445

Enrollment

Unknown

Registered

2019-07-12

Start date

2020-06-17

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late-Life Depression

Interventions

experimental group:rTMS + SSRI drugs

control group:False rTMS+SSRI drugs

Eligibility

Sex/Gender

All

Age

60 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Outpatients or hospitalized elderly depressed patients aged 60 to 75 years; (2) Meets the diagnostic criteria for ICD-10 depressive episodes or recurrent depressive disorder; (3) The total score of the 17 versions of the Hamilton Depression Scale (HAMD) is >17 points; (4) Right hand, has not used rTMS treatment before; (5) All participants participated voluntarily and signed informed consent before the enrollment study.

Exclusion criteria

Exclusion criteria: (1) Other mental illnesses other than depression; (2) Other systemic diseases and depression caused by organic brain diseases; (3) Have a history of severe brain trauma and seizures; (4) A serious history of systemic diseases such as the cardiovascular system, respiratory system, and immune system; (5) History of abuse of alcohol and morphine drugs.

Design outcomes

Primary

Measure	Time frame
HamiltonDepressionScale-17;RBANS;	—

Countries

China

Contacts

Public ContactMa Xin

Beijing Anding Hospital, Capital Medical University

maxinanding@vip.163.com+86 13701364608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026